Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease.

Jennie CaoAndy ShonLuke YoonAya KamayaJustin Ruey Tse

Published in: European radiology (2024)

Performance of LI-RADS is unknown in non-cirrhotic patients with steatotic liver disease. LI-RADS 5 category showed a high pooled specificity of 91-97% for hepatocellular carcinoma. LI-RADS can non-invasively risk stratify focal liver observations in non-cirrhotic patients with steatotic liver disease.

Keyphrases

ion batteries
contrast enhanced
solid state
magnetic resonance imaging
computed tomography
clinical trial
magnetic resonance
image quality
pet ct
double blind